Vascular contributions to cognitive impairment and dementia (VCID) is understood to be the second most common cause of dementia after Alzheimer's disease, and is also a frequent comorbidity with Alzheimer's disease. While VCID is widely acknowledged as a key contributor to dementia, the mechanistic underpinnings of VCID remain poorly understood. In this review, we address the potential role of astrocytes in the pathophysiology of VCID. The vast majority of the blood vessels in the brain are surrounded by astrocytic end-feet. Given that astrocytes make up a significant proportion of the cells in the brain, and that astrocytes are usually passively connected to one another through gap junctions, we hypothesize that astrocytes are key mediators of cognitive impairment because of cerebrovascular disease. In this review, we discuss the existing body of literature regarding the role of astrocytes at the vasculature in the brain, and the known consequences of their dysfunction, as well as our hypotheses regarding the role astrocytes play in VCID.
VCID
Vascular contributions to cognitive impairment and dementia (VCID) are acknowledged to be the second most common cause of dementia after Alzheimer's disease (AD), with up to 30% of dementia cases ascribed to VCID (Levine and Langa 2011) . VCID is also observed as a comorbidity with other common dementias including AD, with estimates of approximately 60% of AD patients showing significant VCID (Bowler et al. 1998; Kammoun et al. 2000; Langa et al. 2004) . Dementia symptoms such as confusion, disorientation, and trouble understanding speech can occur following a major stroke, making stroke the most obvious, acute cause of VCID. However, the majority of VCID cases, in particular those composing AD co-morbidities, are those that have more subtle pathophysiologies such as microinfarcts (microscopic ischemic events), chronic cerebral hypoperfusion, cerebrovascular occlusions, and cerebral microhemorrhages (Levine and Langa 2011) . Important risk factors for VCID include lacunar and larger cerebral infarct in the brain that serve as pathological markers of clinical or subclinical stroke (Snyder et al. 2015) . Pathologies such as macro-and microinfarcts and vessel disease [e.g., atherosclerosis, arteriosclerosis, and cerebral amyloid angiopathy (CAA)] often produce ischemic brain injury. These pathologies are commonly detected in the aging brain and have been shown to be independent risk factors for cognitive impairment and dementia (Jiwa et al. 2010 ).
There remains debate in the dementia field as to whether AD and VCID processes synergize or are simply independent, additive processes. Supporting synergistic effects of the pathologies, VCID and AD share some molecular mechanisms including neuroinflammation and brain metabolic changes. One such area of common mechanisms surrounds clearance pathways of beta-amyloid (Ab). In brains of individuals with AD, a decrease in blood flow has been observed prior to Ab deposition. This suggests that changes in the cerebrovasculature impair clearance of Ab, accelerating the progression of AD (Snyder et al. 2015) .
The innate immune system represents another potential area of overlap between AD and vascular disease. Chronic inflammation around plaques and tangles is frequently found in both human and mouse AD neuropathological studies. Genome wide association studies (GWAS) suggest microglia and infiltrating monocytes may drive AD pathogenesis. Blood-brain barrier (BBB) disruption is commonly found in postmortem brain tissue suggesting an intersection point to immune infiltration and VCID (Arvanitakis et al. 2011; Smith et al. 2012) . In this review, we will focus on the potential role of the neurovascular astrocyte in VCID pathophysiology.
Neurovascular unit
The neurovascular unit is comprised primarily of vascular endothelial cells, pericytes, astrocytes, and neurons ( Fig. 1) . However, in recent years, the cellular anatomy has been extended to include both microglia and perivascular macrophages (Keaney and Campbell 2015) . The neurovascular unit functions to regulate local cerebral blood flow, BBB permeability, neuroimmune responses, and neurovascular remodeling (Stanimirovic and Friedman 2012; Kapasi and Schneider 2016) . Endothelial cells of the neurovascular unit line the cerebral vasculature forming the BBB. Tight junctions of the BBB express specific transporters and thereby limit the passage of substrates between cells (Keaney and Campbell 2015) . Pericytes have elongated processes that ensheath CNS vessel walls and serve important roles in regulating capillary diameter, cerebral blood flow, and extracellular matrix protein secretion (Winkler et al. 2011; Keaney and Campbell 2015) . Finally, astrocytes aid in supporting and protecting neurons by maintaining homeostatic concentrations of specific ions and neurotransmitters while also regulating cerebral blood flow by directly interacting with endothelial cells through their specialized end-feet processes (Keaney and Campbell 2015) . The role the individual cell types play in the regulation of blood flow and brain metabolism has been thoroughly reviewed by others. This review specifically focuses on the astrocytes, and their potential role in the pathophysiology of VCID.
Neurovascular astrocytes
Astrocytes play several key roles in maintaining the health of neurons. In addition to their recognized role in maintaining synapses through regulation of glutamate, astrocytes also have a key role in maintenance of ionic and osmotic homeostasis in the brain (Simard and Nedergaard 2004) . The cerebrovasculature of the brain, primarily arterioles and capillaries, are almost completely ensheathed by astrocytic processes called astrocytic end-feet. The astrocytic end-foot is a specialized unit that functions to maintain the ionic and osmotic homeostasis of the brain (Amiry-Moghaddam et al. 2003; Simard and Nedergaard 2004) . Astrocytic end-feet express a number of channels indicative of their specialized functions. End-feet-enriched channels include the aquaporin 4 (AQP4) water channel, the inwardly rectifying K + channel Kir4.1, and the Ca 2+ -dependent K + channel MaxiK (Dunn and Nelson 2010; Strohschein et al. 2011) . The astrocytic end-foot is anchored to the vascular basement membranes via the a-b dystroglycan complex (Noell et al. 2011; Gondo et al. 2014 ) (schematic shown in Fig. 2 ).
Potassium buffering
Neurons maintain a resting membrane potential (rmp) of approximately À60 to À70 mV. A classic experiment by Hodgkin and Katz in 1949 using the squid giant axon demonstrated that this rmp is determined by the K + concentration gradient across the membrane (high intracellular K + , low extracellular K + ). They showed that increasing the extracellular K + concentration results in the rmp being less negative (Hodgkin and Katz 1949) . When an action potential is initiated, the membrane depolarizes and Na+ enters the neuron. The neuron must reach a threshold in order to fire an action potential. This threshold varies among different neurons but is approximately À40 to À50 mV. After the peak membrane potential of approximately +60 mV is reached, the membrane repolarizes by inactivation of Na+ channels and an increase in K + permeability. There is a brief hyperpolarization (undershoot) where the K + permeability is even greater than at rest. This also prevents another rapid depolarization (termed the refractory period) (Ritchie and Straub 1975) . The efflux of K + ions during action potential firing must be removed in order for the membrane to adequately repolarize and reset channel function for the next electrical signal to occur (Kofuji and Newman 2004 ).
An essential function of the astrocytes surrounding the neurons is to maintain the neuronal rmp by controlling the extracellular potassium concentration, a process termed potassium siphoning (Newman et al. 1984) . It has been shown that through Kir4.1 channels (Neusch et al. 2006 ) and the connexin 43-containing gap junctions, the astrocytes are able to take up this excess K + and move it via their gap junctions either out into the circulation via the astrocytic endfeet or to an area of the brain lacking K + (Wallraff et al. 2004) . Genetic deletion of the Kir4.1 channel from astrocytes has a dramatic effect in mice. Mice lacking the Kir4.1 channel only live 25 days, during which they suffer from seizures, ataxia, and tremor. Electrophysiological studies in these mice reveal significant impairment of potassium uptake by astrocytes, decreased spontaneous action potential frequency and amplitude, and increased LTP (Djukic et al. 2007) . Other potassium channels expressed by astrocytes include the BK (also known as slo-1 or MaxiK), which is polarized to the end-feet (Price et al. 2002) , and a family of potassium channels called the tandem-pore 2P channels, named because they have two pore domains. There are numerous subtypes within this class of potassium channel, with each subtype exhibiting different properties. However, the recent discovery of this new and diverse class of potassium channels [TASK-1 (acid-sensitive) (Kindler et al. 2000) , TASK-2 (high pH-activated), TASK-3 (acid-sensitive), and TREK-2 (mechanosensitive) (Skatchkov et al. 2006) ] and the presence of these 2p-domain potassium channels on astrocytes suggest a functional role in the potassium-buffering function of astrocytes.
Ionic movement across cell membranes is commonly coupled with movement of water and with the maintenance of osmotic equilibrium. Net transport of water always has to be driven by osmotic forces because of solute movement as there is no primary active transport, ATP-driven, water pump (Kimelberg 2004) . Most water movement into and out of cells occurs via water channels in the plasma membrane. These water channels are called the aquaporins and to date, 11 subtypes have been found in mammals. Six aquaporins have been described in the rodent brain (AQP1, 3, 4, 5, 8, and 9) (Badaut et al. 2002) . Of these, aquaporin 4 and 9 have been best described. Aquaporin 9 is found in periventricular glia suggesting that it contributes to water movement between the CSF and brain parenchyma. Aquaporin 4, however, is expressed by astrocytes in the neurovascular unit and is highly polarized to the end-foot membrane. Aquaporin 4 immunoreactivity is strongly expressed on the majority of the cerebrovasculature where it has been shown to bind to asyntrophin (Amiry- Moghaddam et al. 2003 Moghaddam et al. , 2004a Wilcock et al. 2009; Camassa et al. 2015) . Interestingly, when a-syntrophin is deleted in mice, aquaporin 4 is no longer localized to astrocytic end-feet. The mislocalization of aquaporin 4 in the a-syntrophin knockout mice is associated with significant functional defects including prolonged seizure durations with slowed potassium kinetics in the brain extracellular space. Potassium clearance deficits are also observed in a-syntrophin-deficient mice, where aquaporin 4 is not properly targeted to the cell membrane (5).
A common link between the Kir4.1, BK, and aquaporin 4 channels at the astrocytic end-feet appears to be a shared anchoring protein, dystrophin 1. The brain expresses a short isoform of dystrophin 1 named Dp71 (48). Dp71 has been found to be involved in anchoring the Kir4.1, BK, and aquaporin 4 channels (14, 27). Dystrophin 1 complexes with a-syntrophin forming the end-foot anchoring complex.
Glutamate homeostasis
Another critical way that astrocytes affect neuronal excitability and signaling is through the regulation of extracellular glutamate levels using multiple excitatory amino acid transporters (EAAT). Although essential for interneuronal communication within the brain, glutamate can become a powerful excitotoxin if levels are not maintained within a particular range. Moreover, loss and/or disruption of endfeet, similar to that described above for VCID mouse models (Wilcock et al. 2009; Sudduth et al. 2017) , are also found in disease models where excitotoxic damage is prominent (Alvestad et al. 2013; Gondo et al. 2014) . Synapses are particularly vulnerable to excitotoxic insults and are lost at very early stages of cognitive decline associated with Alzheimer's disease. In some brain regions, like the hippocampus, the EAAT2 isoform (Glt-1, mouse homolog) mediates the bulk of astrocyte-dependent glutamate uptake and is therefore one of the most important mechanisms for protecting against excitotoxicity. Numerous studies show that the expression of EAAT2, or the functional uptake of glutamate through this transporter, is reduced in neurodegenerative diseases and/or animal models of disease including mild cognitive impairment and AD (Masliah et al. 1996; Abdul et al. 2009; Simpson et al. 2010) , amyotrophic lateral sclerosis (Rothstein et al. 1992 ), Parkinson's disease (Chung et al. 2008) , and Alexander's disease (Tian et al. 2010) , to name a few. Moreover, signs of neural network hyperexcitability in many disease models are suppressed by genetic and pharmacological manipulations that promote glutamate uptake through EAATs, leading to the improved structural integrity and viability of neurons (Sheldon and Robinson 2007) .
Intracellular mechanisms that negatively regulate EAAT2/ Glt-1 expression, including the calcineurin/nuclear factor of activated T cells (Sama et al. 2008) , are found at elevated levels in astrocytes associated with AD pathology (Abdul et al. 2009 ), Parkinson's disease (Caraveo et al. 2014) , excitotoxic injury (Neria et al. 2013) , and/or traumatic brain injury . In mouse models of AD, inhibition of nuclear factor of activated T cells' activity, selectively in astrocytes, restored EAAT2/Glt-1 expression, quelled neuronal hyperexcitability, and improved synaptic function and cognition Sompol et al. 2017) . While EAAT2 levels have yet to be systematically investigated in conjunction with small vessel damage associated with VCID, recent evidence from our laboratories shows that activated astrocytes enveloping microinfarcts express high levels of a proteolyzed, activated form of calcineurin (Pleiss et al. 2016) , suggesting that the expression/function of EAAT2 in these regions may be adversely affected. Ongoing work in our laboratories is investigating this possibility and determining whether astrocyte-dependent glutamate dysregulation is a key feature of VCID mouse models).
Dementia-related astrocytic end-foot disruption
Significant disruptions of astrocytic end-foot function have been reported in many neurological conditions including ischemia (Frydenlund et al. 2006 ), brain tumors (Saadoun et al. 2003) , epilepsy (Eid et al. 2005) , and brain contusion (Saadoun et al. 2003) . In the course of our own research, we have found similar astrocytic end-foot disruption in mouse models of AD, human AD with CAA, and a mouse model of VCID (Wilcock et al. 2009; Sudduth et al. 2017) .
CAA
Cerebral amyloid angiopathy (CAA) defines the deposition of amyloid in the brain vasculature; primarily smaller arteries and arterioles. Our studies have shown that high levels of CAA, whether in a mouse model of amyloid deposition or in human AD brain, results in a decrease in the numbers of astrocytic processes contacting the vasculature in the cerebral cortex and hippocampus. Clasmatodendrosis is the term given to degenerated astrocytes that has primarily been demonstrated in Binswanger's disease, a form of VCID characterized by diffuse white matter lesions (Akiguchi et al. 1997) . In our mouse and human studies, we examined astrocytic end-foot changes in more detail by examining the levels of channels known to be polarized to the end-foot; aquaporin 4 water channel and several potassium channels. Aquaporin-4 is a water channel highly polarized to the astrocytic end-feet (Yang et al. 1995) . Transgenic mice with high levels of CAA have significant reductions in aquaporin-4-positive staining associated with the blood vessels. Interestingly, we showed that there was no change in total protein expression or gene expression of aquaporin-4, suggesting that the effect is specific to the distribution of aquaporin 4 protein. Astrocytic end-feet are highly enriched with the inward rectifying potassium channel, Kir4.1 (Higashi et al. 2001 ) and the BK calcium-dependent potassium channel (Price et al. 2002) , which are frequently co-anchored with aquaporin-4. Kir4.1 and BK gene and protein expression were significantly decreased in human AD and transgenic mice with high levels of CAA compared to low levels of CAA. (Wilcock et al. 2009 ). To confirm that the BK and Kir4.1 changes were not indicative of a more global decrease in potassium channel expression, we examined Kv1.6 levels. The voltage gated, delayed rectifier Kv1.6 channel expression, which is globally distributed on astrocytes (Smart et al. 1997) , was not altered in any of the mouse strains or in the AD brain, irrespective of CAA levels. Overall, we concluded that CAA may significantly contribute to the observed neurovascular unit pathology and may directly alter neuronal excitability through changes in astrocyte channels and function (Wilcock et al. 2009 ).
VCID
Our group has been developing the hyperhomocysteinemia (HHcy) model that emulates multiple VCID pathologies including neuroinflammation, cognitive impairment, and blood-brain barrier breakdown culminating in microhemorrhages throughout the cerebral cortex and, less frequently, hippocampus (Sudduth et al. 2013) . HHcy is induced through dietary modification that eliminates vitamins B6 and B12, as well as folic acid, from the mouse chow; all of which are essential co-factors for the enzymes responsible for the clearance of homocysteine. To determine astrocytic changes in our HHcy model, we examined the astrocytes, and astrocytic end-feet, at 6, 10, and 14 weeks on diet in wild-type mice. We performed histological and biochemical assessment of astrocytic end-foot markers, as well as behavior and neuroinflammation. Overall, we found astrocytic end-foot disruption characterized by a reduction in Dp71 dystrophin-1 labeling, concurrent with reduced vascular labeling for AQP4, and lower protein/mRNA levels for Kir4.1 and MaxiK/BK potassium channels. The first observed astrocytic changes occurred after 10 weeks on diet, and there was a further reduction at 14 weeks on diet. The expression of the end-foot channels was not reduced as a consequence of a reduced vessel density as we did not see any reduction in total vessel number labeled with collagen IV. Importantly, mice exhibit significant cognitive impairment after being on diet for only 10 weeks and impairment is even more pronounced at the 14 week time-point. These observations suggest that HHcy leads to astrocyte end-feet disruption, which is likely to have significant implications for both potassium homeostasis and neurovascular coupling.
An a-b dystroglycan complex anchors the astrocytic endfoot to the vascular basement membranes (Fig. 2) (Noell et al. 2011; Gondo et al. 2014) . There are many proteinases that are capable of degrading such protein complexes, however, matrix metalloproteinase 9 (MMP9) (Michaluk et al. 2007 ) appears to be a major degrading enzyme of the dystroglycans, specifically b-dystroglycan. MMP9 shows high expression levels in astrocytes (Yin et al. 2006) . We have focused our studies on MMP9 both because of its high expression in astrocytes and also because MMP9 is regulated through the neuroinflammatory responses, specifically IL-1b and tumor necrosis factor alpha (Chakrabarti et al. 2006; Loesch et al. 2010; Klein and Bischoff 2011) . In the HHcy mouse model, microglial activation was apparent at all time points examined, including the earliest 6-week time-point, suggesting that the pro-inflammatory responses and microglial activation (measured by CD11b immunohistochemistry) precedes astrocytic changes. We also showed that both IL-1b and tumor necrosis factor alpha expression, as well as IL-12 and IL-6, were increased at all time points examined. These data are consistent with our previous reports of induction of a pro-inflammatory state by HHcy (Sudduth et al. 2013 (Sudduth et al. , 2014 . A detailed review focusing on the biology of MMP9 was published in 2016 (Weekman and Wilcock 2016) .
Working hypothesis
We hypothesize that perivascular neuroinflammation activates MMP9, which degrades the dystrophin-dystroglycan complex anchoring the end-foot to the basement membrane of the vasculature. This will lead to impaired neurovascular coupling and impaired potassium homeostasis, increasing neuronal excitability and ultimately leading to cognitive deficits (Fig. 3 ).
Summary and conclusions
In summary, neurovascular astrocytes have many critical functions in the brain, and their disruption likely has significant consequences on neuronal function. Further work specifically addressing the role of astrocytes in VCID, and specifically identifying functional consequences of our descriptive findings, is necessary to elucidate their role and ultimately identify potential therapeutic targets.
